Langenskiöld M, Smidfelt K, Karlsson A, Bohm C, Herlitz J, Nordanstig J
Department of Vascular Surgery, Sahlgrenska University Hospital and Institute of Medicine, Department for Molecular and Clinical Medicine, The Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
The Centre for Pre-Hospital Research, University of Borås, Borås, Sweden.
Eur J Vasc Endovasc Surg. 2017 Aug;54(2):235-240. doi: 10.1016/j.ejvs.2017.04.010. Epub 2017 Jun 3.
Acute lower limb ischaemia (ALLI) is a potentially fatal, limb threatening medical emergency. Early treatment is essential for a good outcome. The aim was to describe the early chain of care in ALLI focusing on lead times and emergency management in order to identify weak links for improvement.
This was a retrospective, descriptive case study. This study analysed the medical records of all patients with a main discharge diagnosis of ALLI between January 2009 and December 2014. Predetermined emergency care data on lead times, diagnosis recognition, presenting symptoms, emergency care treatment and outcome were collected for patients who were transported by the Emergency Medical Service (EMS) and those who were not.
In total, 552 medical records were audited of which 195 patients fulfilled the inclusion criteria and were analysed. Among them were 117 (60%) transported by the EMS. The median time from symptom onset to revascularisation was 23 (interquartile range [IQR] 10-55; EMS transported) and 93 (IQR 42-152, not EMS transported) hours (p < .01). The time from symptom onset to arrival in hospital was 5 (IQR 2-26; EMS transported) and 48 (IQR 6-108; not EMS transported) hours. After arrival in hospital, the median time to first doctor evaluation was 51 (IQR 28-90; EMS transported) and 80 (IQR 44-169; not EMS transported) minutes, p = .01. Low molecular weight heparin (LMWH) was given to 72% of patients in the emergency department (ED) and a multivariate analysis showed that the use of LMWH was associated with a more favourable outcome.
Both the time spent in the ED and the time from the onset of symptoms to revascularisation were considerably longer than optimal. Time delays in the early treatment chain can mainly be attributed to "patient delay" and a considerable time spent in hospital before revascularisation. The use of LMWH as an integral part of ED management was associated with a better outcome.
急性下肢缺血(ALLI)是一种潜在致命、威胁肢体的医疗急症。早期治疗对于取得良好预后至关重要。本研究旨在描述ALLI的早期医疗照护流程,重点关注各个环节的时间间隔以及急救处理情况,以便找出可改进的薄弱环节。
这是一项回顾性描述性病例研究。本研究分析了2009年1月至2014年12月期间所有主要出院诊断为ALLI的患者的病历。收集了通过紧急医疗服务(EMS)转运患者和未通过EMS转运患者的预定急救数据,包括时间间隔、诊断识别、症状表现、急救治疗及预后情况。
共审核了552份病历,其中195例患者符合纳入标准并进行了分析。其中117例(60%)由EMS转运。从症状出现到血管再通的中位时间在由EMS转运的患者中为23小时(四分位间距[IQR]10 - 55小时),在未由EMS转运的患者中为93小时(IQR 42 - 152小时)(p <.01)。从症状出现到入院的时间在由EMS转运的患者中为5小时(IQR 2 - 26小时),在未由EMS转运的患者中为48小时(IQR 6 - 108小时)。入院后,首次医生评估的中位时间在由EMS转运的患者中为51分钟(IQR 28 - 90分钟),在未由EMS转运的患者中为80分钟(IQR 44 - 169分钟),p = 0.01。72%的患者在急诊科(ED)接受了低分子量肝素(LMWH)治疗,多因素分析显示使用LMWH与更有利的预后相关。
在急诊科所花费的时间以及从症状出现到血管再通的时间均明显长于最佳时间。早期治疗环节的时间延迟主要可归因于“患者延误”以及血管再通前在医院花费的大量时间。在ED管理中使用LMWH作为整体治疗的一部分与更好的预后相关。